The great and the good of pharma and biotech descended on London to give investors updates on how their businesses are progressing at this year’s Jefferies conference, and provided insights
Endeavor BioMedicines has completed a third-round financing, raising an impressive $132.5 million to fund trials of its two clinical-stage drug candidates for pulmonary fi
It’s 2024, and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another.